<DOC>
	<DOCNO>NCT02518113</DOCNO>
	<brief_summary>The main purpose study evaluate safety study drug know LY3039478 combination dexamethasone participants T-cell acute lymphoblastic leukemia T-cell lymphoblastic lymphoma ( T-ALL/T-LBL ) .</brief_summary>
	<brief_title>A Study LY3039478 Combination With Dexamethasone Participants With T-ALL/T-LBL</brief_title>
	<detailed_description />
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Have acute Tcell lymphoblastic leukemia ( TALL ) Tcell lymphoblastic lymphoma ( TLBL ) . TALL TLBL participant relapsed/refractory disease . Have least 60 day prior hematopoietic stem cell transplantation ( SCT ) first dose study drug . Have performance status 0 2 Eastern Cooperative Oncology Group ( ECOG ) scale adult . Lansky score &gt; 50 % participant &lt; 16 year old . Have adequate organ function . Are least : adult Phase 1 Part A Phase 2 : ≥16 year old time screen pediatric Phase 1 Part B : 2 &lt; 16 year old Men woman reproductive potential : Must agree use reliable method birth control study 3 month follow last dose study drug ( ) country requirement , whichever longer . Females childbearing potential : Have negative serum pregnancy test ≤7 day first dose study drug also must breastfeed . Are able swallow capsule tablet . Have previously complete withdrawn study study investigate LY3039478 Notch inhibitor . Have evidence uncontrolled , active infection &lt; 7 day prior administration study medication . Have current recent gastrointestinal disease chronic intermittent diarrhea , disorder increase risk diarrhea , inflammatory bowel disease . Have active leukemic involvement central nervous system ( CNS ) .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>